ATE496932T1 - Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10 - Google Patents

Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10

Info

Publication number
ATE496932T1
ATE496932T1 AT02718923T AT02718923T ATE496932T1 AT E496932 T1 ATE496932 T1 AT E496932T1 AT 02718923 T AT02718923 T AT 02718923T AT 02718923 T AT02718923 T AT 02718923T AT E496932 T1 ATE496932 T1 AT E496932T1
Authority
AT
Austria
Prior art keywords
ccr5
antibody
chemokine receptor
protein chemokine
hdgnr10
Prior art date
Application number
AT02718923T
Other languages
English (en)
Inventor
Viktor Roschke
Craig Rosen
Steven Ruben
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2001/004153 external-priority patent/WO2001058916A2/en
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Priority claimed from PCT/US2002/003634 external-priority patent/WO2002064612A2/en
Application granted granted Critical
Publication of ATE496932T1 publication Critical patent/ATE496932T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02718923T 2001-02-09 2002-02-08 Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10 ATE496932T1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
PCT/US2001/004153 WO2001058916A2 (en) 2000-02-09 2001-02-09 Antibodies to ccr5
US09/779,880 US20020061834A1 (en) 2000-02-09 2001-02-09 Human G-protein Chemokine receptor (CCR5) HDGNR10
US29725701P 2001-06-12 2001-06-12
US31045801P 2001-08-08 2001-08-08
US32844701P 2001-10-12 2001-10-12
US34172501P 2001-12-21 2001-12-21
PCT/US2002/003634 WO2002064612A2 (en) 2001-02-09 2002-02-08 Human g-protein chemokine receptor (ccr5) hdgnr10

Publications (1)

Publication Number Publication Date
ATE496932T1 true ATE496932T1 (de) 2011-02-15

Family

ID=46150070

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02718923T ATE496932T1 (de) 2001-02-09 2002-02-08 Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10

Country Status (5)

Country Link
KR (1) KR20030081437A (de)
AT (1) ATE496932T1 (de)
AU (1) AU2008209670A1 (de)
MX (1) MXPA03007186A (de)
NZ (1) NZ527126A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2857168C (en) * 2011-12-01 2020-10-27 Protevobio, Inc. Protein inhibitors to complement and vegf pathways and methods of use thereof

Also Published As

Publication number Publication date
KR20030081437A (ko) 2003-10-17
MXPA03007186A (es) 2005-07-01
NZ527126A (en) 2007-04-27
AU2008209670A1 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
Scallon et al. Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions
CA2430135A1 (en) Recombinant anti-cd30 antibodies and uses thereof
TWI335336B (de)
CA2213833A1 (en) Vascular endothelial cell growth factor antagonists
KR20210005872A (ko) 이작용성 단백질 및 이의 작제물
CN117024599A (zh) 双特异性信号传导剂及其用途
CN110573172A (zh) 靶向的工程化干扰素及其用途
US20210238264A1 (en) Therapeutic targeting of non-cellular structures
US20090123456A1 (en) Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
TW201023855A (en) Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan
EP1798242A3 (de) Anti-IGF-IF-Antikörper und ihre Anwendungen
JP2005506035A5 (de)
NZ515464A (en) Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
MXPA05007823A (es) Composicion y tratamiento de enfermedades desmielizantes y paralisis por administracion de agentes remielinizantes.
JP2004518624A5 (de)
JP2018535948A5 (de)
CA3050601A1 (en) Immune-cell targeted bispecific chimeric proteins and uses thereof
KR20090122910A (ko) 류마티스 관절염의 진단 및 치료에 사용되는 항-cd6 단일클론성 항체를 포함하는 약학 조성물
Döring et al. Identification and characterization of a TNFα antagonist derived from a monoclonal antibody
Li et al. Cholera toxin B subunit binding to an antigen-presenting cell directly co-stimulates cytokine production from a T cell clone
KR20200040881A (ko) 항-pacap 항체
Abe et al. Role of 55-and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
ATE496932T1 (de) Humaner g-protein-chemokinrezeptor (ccr5) hdgnr10
Lochner et al. Generation of neutralizing mouse anti-mouse IL-18 antibodies for inhibition of inflammatory responses in vivo
NZ337601A (en) Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics by inhibiting IgE expression